stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Frei - Play StoreApp Store
InstallierenInstallieren
logo
Cartesian Therapeutics IncRNAC
$6.367.63%-0.525
Nachbörslich: 6.36+0.00 +0.08%

Cartesian Therapeutics Inc (RNAC)

Finanzdaten der Cartesian Therapeutics Inc-Aktie (RNAC)

*Alle Zahlen in Millionen
Enddatum des Zeitraums2026-09-302026-06-302026-03-312025-12-312025-09-30
Periodenlänge3 Monate3 Monate3 Monate3 Monate3 Monate
Revenues
-
-0.080.950.45
14.25%25.00
29.1626.5879.5921.52
Research and Development
23.53%15.62
20.4319.4614.6913.80
Operating Income/Loss
14.25%-25.00
-29.16-26.50-78.64-21.07
Nonoperating Income/Loss
69.88%13.53
44.92-12.68--
172.75%-11.47
15.77-39.18-92.58-35.90
Attributable To Parent
172.75%-11.47
15.77-39.18-92.58-35.90
Basic Average Shares
2.86%30.31
29.4726.860.0126.00
Diluted Average Shares
1.50%30.31
29.8626.860.0126.00
Basic Earnings Per Share
180.85%-0.38
0.47-1.46-3.57-1.38
Diluted Earnings Per Share
182.61%-0.38
0.46-1.46-3.57-1.38

Ähnlich wie RNAC